Founders get this wrong more often than they admit. They walk into a funding conversation with a number in their head, an investor pushes back, and suddenly they can’t explain how they got there. That’s a bad spot to be in.

Startup valuation isn’t a single calculation. It’s a negotiation grounded in methods, and the method that matters most depends on your stage, your industry, and what you’re actually trying to accomplish. Get it wrong in either direction and it costs you. Overshoot and you create a valuation cliff that haunts your next round. Undershoot and you give away equity you’ll spend years regretting.

Here’s a practical breakdown of how startup valuation actually works, what methods investors use at different stages, and what they’re really looking at when they decide what your company is worth.

Why startup valuation is harder than it looks

Valuing a mature business is annoying but manageable. There’s revenue, cash flow, margin history, comparable transactions. You have something to work with.

Valuing an early-stage startup is a different problem entirely. You’re pricing future potential, not present performance. Half the inputs are assumptions in startup valuation. And the number you land on isn’t just a financial figure, it determines equity splits, signals credibility to future investors, and sets expectations you’ll have to beat.

The 5 valuation methods investors actually use at different stages

1. Comparable company analysis

This is where most founders should start. Find businesses in your sector at a similar stage with publicly available funding data and compare against them. What did a company like yours raise at, and what multiple did that imply? Does annual recurring revenue (ARR) or monthly recurring revenue (MRR) multiply user growth rates or not?

No two startups are the same, and market conditions from a few months ago may not reflect today’s appetite. But it gives you an anchor grounded in actual market behaviour rather than a spreadsheet projection nobody believes.

2. The Berkus valuation method

The Berkus valuation method is built specifically for pre-revenue startups. Dave Berkus, a veteran angel investor, designed this to stop founders from building absurd valuations on projected revenues that virtually no early-stage company actually hits on schedule.

The idea is to assign dollar values across five dimensions: the quality of the idea itself, the prototype or proof of concept, the team, strategic relationships, and early product rollout or sales. This method is blunt but honest about what an unproven startup is actually worth.

3. Scorecard method

The Scorecard method takes comparable transactions as a baseline, then adjusts up or down based on how your startup stacks up across key factors: team strength, market size, product stage, competitive environment, and traction. Each factor gets a weighting, you score against the benchmark, and you arrive at an adjusted valuation.

It is more nuanced than Berkus and more grounded than pure projection or company analysis. Most angel investors who do this often have their own version of it, whether they call it that or not.

4. Venture capital method

The venture capital (VC) method works backwards from an exit. The investor estimates what the company could be worth at acquisition or IPO, applies their target return multiple, and reverse-engineers the pre-money valuation they’re willing to accept today.

This is the method where founders and investors often talk past each other. The investor is pricing in their fund’s required returns. The founder is pricing in optimism. Understanding how a VC is actually running this maths puts you in a much better negotiating position.

5. Discounted cash flow

Also known as DCF, this method applies a discount rate to projected future cash flows to arrive at a present value. In theory, it’s rigorous. In practice, for early-stage startups, it’s only as good as the assumptions baked into the projections, and those assumptions are usually speculative at best.

Most investors don’t rely on DCF alone for early rounds. But it becomes more relevant as the company matures and actual financial history starts to anchor the projections.

What metrics actually move the needle in startup valuation?

Methods set the framework. Metrics fill it in. These are the numbers investors will pull apart before they write a check.

• ARR and MRR: For SaaS and subscription businesses, annual and monthly recurring revenue are the foundation. AI companies in 2025 traded at 25 to 30 times ARR in some cases. The multiple you can justify depends on growth rate and retention.
• Revenue growth rate: Year-over-year growth is the headline metric. Early-stage SaaS companies targeting serious investment typically need to show a high percentage of YoY growth. 
• Gross margin: High-margin businesses get higher multiples. A SaaS company at 75% gross margin looks very different to an investor than a logistics startup at 30%. It signals how efficiently the business model scales.
• Lifetime value (LTV) vs cost of acquiring them (CAC): How much revenue does a customer generate over their lifetime relative to what it cost to acquire them? An LTV vs CAC ratio below 3:1 is a concern. Above 5:1 and investors start paying attention.
• Burn multiple: How much are you spending to generate each dollar of new ARR? Investors are now flagging anything above 1.5 as inefficient. In the current climate, capital efficiency matters more than it did three years ago.
• Churn rate: Retention is proof that the product works. High churn undermines every other growth metric. Monthly churn above 2% starts raising questions at most growth-stage rounds.

What investors actually want to see in your startup valuation?

Metrics get you in the room. But what actually moves a valuation up or down in a real investor conversation is mostly qualitative. In 2026, with fewer deals getting done and investors being far more selective, these factors carry more weight than they did three years ago.

• Team credibility: Domain expertise, complementary skills, and evidence of execution matter more than vision alone.
• Product-market fit: Retention, repeat usage, and referrals tell investors whether you’ve found something real.
• Path to profitability: You don’t need to be profitable. You need to show you know how to get there.
• Realistic market sizing: Bottom-up capture strategy beats a top-down TAM slide every time.

Get these right and the valuation conversation gets easier. Get them wrong and no multiple will save the deal.

In a nutshell

Raising at the highest possible valuation sounds like winning. Sometimes it’s the opposite.

If you raise a Seed round at an inflated number and then fail to hit the growth targets that justified it, your Series A investors will either demand a lower valuation or walk. That’s a down round, and down rounds are painful in ways that go beyond the financial maths. They affect team morale, signal to the market that something went wrong, and complicate future fundraising.

A realistic valuation that you can confidently beat is worth more in the long run than an aggressive one you struggle to defend. Build credibility early. Investors remember founders who delivered against their projections, and they tell each other.

Adam Mulligan, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.